JoNel Aleccia is a Senior Correspondent focused on aging and end-of-life issues on the KHN enterprise team. Before joining KHN in November 2016, she was a health reporter for more than a decade, covering regional and national news at outlets including The Seattle Times, NBCNews.com, TODAY.com and MSNBC.com. Before that, she was a reporter, editor and columnist at newspapers in the Northwest. JoNel was a member of reporting teams that won National Press Club Awards for digital journalism focused on the Great Recession and on amputees in the 2010 earthquake in Haiti.
JoNel Aleccia
From this contributor
Despite measles outbreaks, vaccine exemptions easy to obtain in U.S. states
As measles outbreaks continue across the United States, newly revealed health records from Oregon suggest it’s surprisingly easy to opt out of required vaccinations in that state — as in several others.
Despite measles outbreaks, vaccine exemptions easy to obtain in U.S. states
U.S. measles outbreak sends hesitant families scrambling for vaccines
Demand for measles vaccine has surged in the Washington county where the highly contagious virus is linked to more than 50 confirmed illnesses this year — including among people who had previously shunned the shots.
U.S. measles outbreak sends hesitant families scrambling for vaccines
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”